C. Ola Landgren, M.D., Ph.D. (IMAGE)

University of Miami Miller School of Medicine

C. Ola Landgren, M.D., Ph.D.

Caption

C. Ola Landgren, M.D., Ph.D., director of the Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has been named a recipient of the 2027 Precision Medicine World Conference (PMWC) Pioneer Award. The honor recognizes his groundbreaking work advancing minimal residual disease (MRD) as an early measure of treatment effectiveness and an endpoint for accelerated approval of new multiple myeloma therapies.

Credit

Sylvester Comprehensive Cancer Center

Usage Restrictions

Use with attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.